Glen Eagle Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $265K | Sell |
3,694
-140
| -4% | -$10.8K | 0.04% | 234 |
|
|
2025
Q4 | $304K | Hold |
3,834
| – | – | 0.04% | 222 |
|
|
2025
Q3 | $289K | Sell |
3,834
-48
| -1% | -$3.29K | 0.04% | 227 |
|
|
2025
Q2 | $268K | Sell |
3,882
-619
| -14% | -$40.6K | 0.04% | 223 |
|
|
2025
Q1 | $305K | Sell |
4,501
-522
| -10% | -$31.2K | 0.05% | 201 |
|
|
2024
Q4 | $225K | Sell |
5,023
-2,667
| -35% | -$150K | 0.04% | 225 |
|
|
2024
Q3 | $484K | Sell |
7,690
-1,507
| -16% | -$87.9K | 0.08% | 148 |
|
|
2024
Q2 | $543K | Sell |
9,197
-664
| -7% | -$41.5K | 0.1% | 133 |
|
|
2024
Q1 | $786K | Sell |
9,861
-161
| -2% | -$12.3K | 0.15% | 110 |
|
|
2023
Q4 | $791K | Sell |
10,022
-558
| -5% | -$39.7K | 0.16% | 108 |
|
|
2023
Q3 | $739K | Sell |
10,580
-585
| -5% | -$41.5K | 0.17% | 105 |
|
|
2023
Q2 | $772K | Sell |
11,165
-110
| -1% | -$7.83K | 0.18% | 101 |
|
|
2023
Q1 | $838K | Buy |
11,275
+4
| +0% | +$335 | 0.21% | 93 |
|
|
2022
Q4 | $1.05M | Sell |
11,271
-51
| -0.5% | -$4.92K | 0.29% | 73 |
|
|
2022
Q3 | $1.08M | Sell |
11,322
-11
| -0.1% | -$1.09K | 0.31% | 67 |
|
|
2022
Q2 | $1.05M | Sell |
11,333
-78
| -0.7% | -$7.61K | 0.28% | 72 |
|
|
2022
Q1 | $1.15M | Buy |
11,411
+65
| +0.6% | +$6.83K | 0.3% | 71 |
|
|
2021
Q4 | $1.17M | Sell |
11,346
-409
| -3% | -$37.8K | 0.3% | 75 |
|
|
2021
Q3 | $998K | Buy |
11,755
+136
| +1% | +$11.4K | 0.29% | 73 |
|
|
2021
Q2 | $969K | Buy |
11,619
+486
| +4% | +$39.8K | 0.3% | 71 |
|
|
2021
Q1 | $838K | Buy |
11,133
+999
| +10% | +$72.8K | 0.29% | 76 |
|
|
2020
Q4 | $692K | Sell |
10,134
-433
| -4% | -$28.2K | 0.27% | 76 |
|
|
2020
Q3 | $617K | Buy |
10,567
+985
| +10% | +$61.3K | 0.28% | 78 |
|
|
2020
Q2 | $623K | Buy |
9,582
+3,698
| +63% | +$233K | 0.32% | 72 |
|
|
2020
Q1 | $349K | Buy |
5,884
+1,025
| +21% | +$68.4K | 0.24% | 97 |
|
|
2019
Q4 | $361K | Buy |
4,859
+234
| +5% | +$16.4K | 0.19% | 108 |
|
|
2019
Q3 | $292K | Buy |
4,625
+801
| +21% | +$47.5K | 0.19% | 108 |
|
|
2019
Q2 | $208K | Buy |
3,824
+427
| +13% | +$23K | 0.14% | 139 |
|
|
2019
Q1 | $183K | Buy |
3,397
+18
| +0.5% | +$1.11K | 0.13% | 147 |
|
|
2018
Q4 | $221K | Buy |
3,379
+127
| +4% | +$9.48K | 0.19% | 115 |
|
|
2018
Q3 | $256K | Sell |
3,252
-260
| -7% | -$18.6K | 0.18% | 119 |
|
|
2018
Q2 | $226K | Sell |
3,512
-90
| -2% | -$5.93K | 0.18% | 127 |
|
|
2018
Q1 | $224K | Buy |
3,602
+80
| +2% | +$5.74K | 0.18% | 120 |
|
|
2017
Q4 | $255K | Sell |
3,522
-357
| -9% | -$26K | 0.22% | 105 |
|
|
2017
Q3 | $315K | Sell |
3,879
-3,167
| -45% | -$251K | 0.29% | 81 |
|
|
2017
Q2 | $567K | Buy |
7,046
+411
| +6% | +$32.5K | 0.45% | 54 |
|
|
2017
Q1 | $523K | Hold |
6,635
| – | – | 0.45% | 58 |
|
|
2016
Q4 | $524K | Buy |
+6,635
| New | +$537K | 0.47% | 62 |
|
Other funds holding CVS
VCM
VPM
Glen Eagle Advisors's CVS Position: Q1 2026 in Review
Glen Eagle Advisors reduced its CVS Health (CVS) stake by 3.7% in Q1 2026, selling an estimated $10.8K and leaving 3,694 shares worth $265K. The position accounts for 0.04% of the portfolio, ranked #234.
Glen Eagle Advisors first reported a position in CVS in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.17M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Glen Eagle Advisors held 3,694 shares of CVS Health worth $265K as of Q1 2026.
- Glen Eagle Advisors sold 140 CVS Health shares in Q1 2026, an estimated $10.8K.
- CVS Health made up 0.04% of Glen Eagle Advisors's portfolio in Q1 2026, its #234 holding.
- Glen Eagle Advisors first reported a position in CVS Health in Q4 2016 and has held it in 38 quarters since.
- Glen Eagle Advisors's CVS Health position peaked at $1.17M in Q4 2021.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Glen Eagle Advisors's 13F filing for Q1 2026, filed 15 May 2026.